Dea No. 9740
Dea No. 9740 Brand names, Dea No. 9740 Analogs
Dea No. 9740 Brand Names Mixture
- No information avaliable
Dea No. 9740 Chemical_Formula
C22H30N2O2S
Dea No. 9740 RX_link
No information avaliable
Dea No. 9740 fda sheet
Dea No. 9740 msds (material safety sheet)
Dea No. 9740 Synthesis Reference
No information avaliable
Dea No. 9740 Molecular Weight
386.552 g/mol
Dea No. 9740 Melting Point
97 oC
Dea No. 9740 H2O Solubility
76 mg/L
Dea No. 9740 State
Solid
Dea No. 9740 LogP
3.382
Dea No. 9740 Dosage Forms
Liquid; Solution
Dea No. 9740 Indication
Used as an analgesic adjunct in anesthesia and as a primary anesthetic drug in procedures requiring assisted ventilation and in the relief of pain.
Dea No. 9740 Pharmacology
Sufentanil is a synthetic opioid analgesic. Sufentanil interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, sufentanil exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Sufentanil may increase the patient's tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Sufentanil depresses the respiratory centers, depresses the cough reflex, and constricts the pupils.
Dea No. 9740 Absorption
No information avaliable
Dea No. 9740 side effects and Toxicity
LD50: 18.7 mg/kg (IV in mice)
Dea No. 9740 Patient Information
Dea No. 9740 Organisms Affected
Humans and other mammals
